nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—BCHE—Cisplatin—esophageal cancer	0.181	0.512	CbGbCtD
Procainamide—SLC22A2—Cisplatin—esophageal cancer	0.173	0.488	CbGbCtD
Procainamide—BCHE—diaphragm—esophageal cancer	0.0307	0.152	CbGeAlD
Procainamide—SLC22A4—larynx—esophageal cancer	0.0252	0.125	CbGeAlD
Procainamide—SCN11A—digestive system—esophageal cancer	0.00853	0.0423	CbGeAlD
Procainamide—Sunitinib—CSNK1A1—esophageal cancer	0.00815	0.227	CrCbGaD
Procainamide—Sunitinib—SBK1—esophageal cancer	0.00815	0.227	CrCbGaD
Procainamide—DNMT1—epithelium—esophageal cancer	0.00733	0.0363	CbGeAlD
Procainamide—DNMT1—bronchus—esophageal cancer	0.00722	0.0357	CbGeAlD
Procainamide—SLC22A4—neck—esophageal cancer	0.00667	0.033	CbGeAlD
Procainamide—DNMT1—trachea—esophageal cancer	0.00648	0.0321	CbGeAlD
Procainamide—SCN7A—lung—esophageal cancer	0.00606	0.03	CbGeAlD
Procainamide—Sunitinib—MAP3K3—esophageal cancer	0.00565	0.158	CrCbGaD
Procainamide—DNMT1—digestive system—esophageal cancer	0.00557	0.0276	CbGeAlD
Procainamide—SCN9A—lung—esophageal cancer	0.00475	0.0235	CbGeAlD
Procainamide—DNMT1—lung—esophageal cancer	0.00466	0.023	CbGeAlD
Procainamide—SLC22A2—digestive system—esophageal cancer	0.00466	0.023	CbGeAlD
Procainamide—SLC22A4—bronchus—esophageal cancer	0.00447	0.0221	CbGeAlD
Procainamide—SCN7A—lymph node—esophageal cancer	0.00414	0.0205	CbGeAlD
Procainamide—SCN1A—lung—esophageal cancer	0.00408	0.0202	CbGeAlD
Procainamide—SLC22A4—trachea—esophageal cancer	0.00401	0.0199	CbGeAlD
Procainamide—SLC22A3—smooth muscle tissue—esophageal cancer	0.00398	0.0197	CbGeAlD
Procainamide—SCN5A—digestive system—esophageal cancer	0.00393	0.0195	CbGeAlD
Procainamide—Gastrointestinal tract irritation—Capecitabine—esophageal cancer	0.00381	0.0499	CcSEcCtD
Procainamide—SCN10A—lung—esophageal cancer	0.00361	0.0179	CbGeAlD
Procainamide—SLC22A4—digestive system—esophageal cancer	0.00345	0.0171	CbGeAlD
Procainamide—SCN3A—lung—esophageal cancer	0.00329	0.0163	CbGeAlD
Procainamide—SCN9A—lymph node—esophageal cancer	0.00325	0.0161	CbGeAlD
Procainamide—DNMT1—lymph node—esophageal cancer	0.00318	0.0158	CbGeAlD
Procainamide—Sunitinib—CHEK2—esophageal cancer	0.00318	0.0887	CrCbGaD
Procainamide—SLC22A5—bronchus—esophageal cancer	0.00296	0.0146	CbGeAlD
Procainamide—SLC22A4—lung—esophageal cancer	0.00288	0.0143	CbGeAlD
Procainamide—BCHE—bronchus—esophageal cancer	0.00288	0.0143	CbGeAlD
Procainamide—BCHE—smooth muscle tissue—esophageal cancer	0.00282	0.014	CbGeAlD
Procainamide—SLC22A5—trachea—esophageal cancer	0.00266	0.0132	CbGeAlD
Procainamide—SLC22A3—lung—esophageal cancer	0.00262	0.013	CbGeAlD
Procainamide—BCHE—trachea—esophageal cancer	0.00259	0.0128	CbGeAlD
Procainamide—ACHE—lymph node—esophageal cancer	0.00259	0.0128	CbGeAlD
Procainamide—SCN10A—lymph node—esophageal cancer	0.00247	0.0122	CbGeAlD
Procainamide—Pericarditis—Methotrexate—esophageal cancer	0.00234	0.0307	CcSEcCtD
Procainamide—SLC22A5—digestive system—esophageal cancer	0.00229	0.0113	CbGeAlD
Procainamide—SCN3A—lymph node—esophageal cancer	0.00225	0.0112	CbGeAlD
Procainamide—BCHE—digestive system—esophageal cancer	0.00223	0.011	CbGeAlD
Procainamide—Supraventricular tachycardia—Capecitabine—esophageal cancer	0.00208	0.0272	CcSEcCtD
Procainamide—SLC22A4—lymph node—esophageal cancer	0.00197	0.00977	CbGeAlD
Procainamide—Hepatomegaly—Capecitabine—esophageal cancer	0.00192	0.0252	CcSEcCtD
Procainamide—SLC22A5—lung—esophageal cancer	0.00191	0.00945	CbGeAlD
Procainamide—BCHE—lung—esophageal cancer	0.00186	0.0092	CbGeAlD
Procainamide—SLC22A3—lymph node—esophageal cancer	0.0018	0.00889	CbGeAlD
Procainamide—Pleural effusion—Capecitabine—esophageal cancer	0.00178	0.0233	CcSEcCtD
Procainamide—Ventricular fibrillation—Capecitabine—esophageal cancer	0.00178	0.0233	CcSEcCtD
Procainamide—Sunitinib—KDR—esophageal cancer	0.00178	0.0496	CrCbGaD
Procainamide—Body temperature increased—Carboplatin—esophageal cancer	0.00178	0.0233	CcSEcCtD
Procainamide—Lidocaine—EGFR—esophageal cancer	0.00155	0.0433	CrCbGaD
Procainamide—Haemolytic anaemia—Cisplatin—esophageal cancer	0.00149	0.0194	CcSEcCtD
Procainamide—CYP2D6—digestive system—esophageal cancer	0.00147	0.0073	CbGeAlD
Procainamide—Probenecid—ABCC2—esophageal cancer	0.00134	0.0372	CrCbGaD
Procainamide—Pleural effusion—Methotrexate—esophageal cancer	0.00132	0.0173	CcSEcCtD
Procainamide—Aminohippurate—ABCC2—esophageal cancer	0.00132	0.0367	CrCbGaD
Procainamide—SLC22A5—lymph node—esophageal cancer	0.00131	0.00646	CbGeAlD
Procainamide—BCHE—lymph node—esophageal cancer	0.00127	0.00629	CbGeAlD
Procainamide—Lidocaine—CYP2A6—esophageal cancer	0.00127	0.0354	CrCbGaD
Procainamide—Abdominal discomfort—Cisplatin—esophageal cancer	0.00111	0.0145	CcSEcCtD
Procainamide—Oliguria—Methotrexate—esophageal cancer	0.0011	0.0144	CcSEcCtD
Procainamide—Hepatic failure—Capecitabine—esophageal cancer	0.0011	0.0144	CcSEcCtD
Procainamide—Haemolytic anaemia—Capecitabine—esophageal cancer	0.0011	0.0143	CcSEcCtD
Procainamide—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.00107	0.014	CcSEcCtD
Procainamide—Sunitinib—ABCC2—esophageal cancer	0.00105	0.0293	CrCbGaD
Procainamide—Atrial fibrillation—Capecitabine—esophageal cancer	0.00104	0.0137	CcSEcCtD
Procainamide—Renal impairment—Capecitabine—esophageal cancer	0.00104	0.0136	CcSEcCtD
Procainamide—Vasculitis—Methotrexate—esophageal cancer	0.00104	0.0136	CcSEcCtD
Procainamide—Arthritis—Capecitabine—esophageal cancer	0.00102	0.0133	CcSEcCtD
Procainamide—Renal failure—Cisplatin—esophageal cancer	0.00102	0.0133	CcSEcCtD
Procainamide—Cardiac failure—Capecitabine—esophageal cancer	0.00101	0.0133	CcSEcCtD
Procainamide—Lethargy—Capecitabine—esophageal cancer	0.00101	0.0132	CcSEcCtD
Procainamide—Bradycardia—Cisplatin—esophageal cancer	0.000945	0.0124	CcSEcCtD
Procainamide—Cardiac arrest—Capecitabine—esophageal cancer	0.00094	0.0123	CcSEcCtD
Procainamide—Abdominal pain upper—Capecitabine—esophageal cancer	0.000903	0.0118	CcSEcCtD
Procainamide—Flushing—Cisplatin—esophageal cancer	0.000861	0.0113	CcSEcCtD
Procainamide—Cardiac disorder—Cisplatin—esophageal cancer	0.000861	0.0113	CcSEcCtD
Procainamide—Abdominal discomfort—Capecitabine—esophageal cancer	0.000819	0.0107	CcSEcCtD
Procainamide—Hepatic failure—Methotrexate—esophageal cancer	0.000819	0.0107	CcSEcCtD
Procainamide—Neutropenia—Capecitabine—esophageal cancer	0.000799	0.0105	CcSEcCtD
Procainamide—Depression—Capecitabine—esophageal cancer	0.00076	0.00994	CcSEcCtD
Procainamide—Lethargy—Methotrexate—esophageal cancer	0.000751	0.00983	CcSEcCtD
Procainamide—Ill-defined disorder—Cisplatin—esophageal cancer	0.00075	0.00981	CcSEcCtD
Procainamide—Renal failure—Capecitabine—esophageal cancer	0.000749	0.0098	CcSEcCtD
Procainamide—Malaise—Cisplatin—esophageal cancer	0.000729	0.00953	CcSEcCtD
Procainamide—Agranulocytosis—Capecitabine—esophageal cancer	0.000711	0.00931	CcSEcCtD
Procainamide—Convulsion—Cisplatin—esophageal cancer	0.0007	0.00916	CcSEcCtD
Procainamide—Bradycardia—Capecitabine—esophageal cancer	0.000696	0.00911	CcSEcCtD
Procainamide—Myalgia—Cisplatin—esophageal cancer	0.000688	0.009	CcSEcCtD
Procainamide—Discomfort—Cisplatin—esophageal cancer	0.00068	0.00889	CcSEcCtD
Procainamide—Thrombocytopenia—Cisplatin—esophageal cancer	0.000646	0.00845	CcSEcCtD
Procainamide—Cardiac disorder—Capecitabine—esophageal cancer	0.000635	0.00831	CcSEcCtD
Procainamide—Flushing—Capecitabine—esophageal cancer	0.000635	0.00831	CcSEcCtD
Procainamide—Eosinophilia—Methotrexate—esophageal cancer	0.00063	0.00824	CcSEcCtD
Procainamide—Anorexia—Cisplatin—esophageal cancer	0.000628	0.00823	CcSEcCtD
Procainamide—Hypotension—Cisplatin—esophageal cancer	0.000616	0.00806	CcSEcCtD
Procainamide—Chills—Capecitabine—esophageal cancer	0.000614	0.00803	CcSEcCtD
Procainamide—Abdominal discomfort—Methotrexate—esophageal cancer	0.00061	0.00798	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000601	0.00786	CcSEcCtD
Procainamide—Neutropenia—Methotrexate—esophageal cancer	0.000595	0.00779	CcSEcCtD
Procainamide—Dysgeusia—Capecitabine—esophageal cancer	0.000583	0.00763	CcSEcCtD
Procainamide—Benzocaine—ABCB1—esophageal cancer	0.00058	0.0162	CrCbGaD
Procainamide—Decreased appetite—Cisplatin—esophageal cancer	0.000573	0.0075	CcSEcCtD
Procainamide—Depression—Methotrexate—esophageal cancer	0.000566	0.0074	CcSEcCtD
Procainamide—Renal failure—Methotrexate—esophageal cancer	0.000558	0.0073	CcSEcCtD
Procainamide—Ill-defined disorder—Capecitabine—esophageal cancer	0.000553	0.00723	CcSEcCtD
Procainamide—Feeling abnormal—Cisplatin—esophageal cancer	0.000543	0.00711	CcSEcCtD
Procainamide—Malaise—Capecitabine—esophageal cancer	0.000537	0.00703	CcSEcCtD
Procainamide—Agranulocytosis—Methotrexate—esophageal cancer	0.000529	0.00693	CcSEcCtD
Procainamide—Body temperature increased—Cisplatin—esophageal cancer	0.000521	0.00682	CcSEcCtD
Procainamide—Arthralgia—Capecitabine—esophageal cancer	0.000507	0.00664	CcSEcCtD
Procainamide—Myalgia—Capecitabine—esophageal cancer	0.000507	0.00664	CcSEcCtD
Procainamide—Discomfort—Capecitabine—esophageal cancer	0.000501	0.00656	CcSEcCtD
Procainamide—Probenecid—ABCB1—esophageal cancer	0.000491	0.0137	CrCbGaD
Procainamide—Confusional state—Capecitabine—esophageal cancer	0.00049	0.00641	CcSEcCtD
Procainamide—Hypersensitivity—Cisplatin—esophageal cancer	0.000486	0.00636	CcSEcCtD
Procainamide—Aminohippurate—ABCB1—esophageal cancer	0.000485	0.0135	CrCbGaD
Procainamide—Shock—Capecitabine—esophageal cancer	0.000478	0.00626	CcSEcCtD
Procainamide—Thrombocytopenia—Capecitabine—esophageal cancer	0.000476	0.00623	CcSEcCtD
Procainamide—Asthenia—Cisplatin—esophageal cancer	0.000473	0.00619	CcSEcCtD
Procainamide—Cardiac disorder—Methotrexate—esophageal cancer	0.000473	0.00619	CcSEcCtD
Procainamide—Lidocaine—ABCB1—esophageal cancer	0.000472	0.0132	CrCbGaD
Procainamide—Anorexia—Capecitabine—esophageal cancer	0.000463	0.00606	CcSEcCtD
Procainamide—Chills—Methotrexate—esophageal cancer	0.000457	0.00598	CcSEcCtD
Procainamide—Hypotension—Capecitabine—esophageal cancer	0.000454	0.00594	CcSEcCtD
Procainamide—Diarrhoea—Cisplatin—esophageal cancer	0.000451	0.0059	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000443	0.0058	CcSEcCtD
Procainamide—Dysgeusia—Methotrexate—esophageal cancer	0.000434	0.00568	CcSEcCtD
Procainamide—Decreased appetite—Capecitabine—esophageal cancer	0.000422	0.00553	CcSEcCtD
Procainamide—Vomiting—Cisplatin—esophageal cancer	0.000419	0.00549	CcSEcCtD
Procainamide—Ill-defined disorder—Methotrexate—esophageal cancer	0.000411	0.00538	CcSEcCtD
Procainamide—Feeling abnormal—Capecitabine—esophageal cancer	0.000401	0.00524	CcSEcCtD
Procainamide—Malaise—Methotrexate—esophageal cancer	0.0004	0.00523	CcSEcCtD
Procainamide—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000397	0.0052	CcSEcCtD
Procainamide—Nausea—Cisplatin—esophageal cancer	0.000392	0.00513	CcSEcCtD
Procainamide—Sunitinib—ABCB1—esophageal cancer	0.000387	0.0108	CrCbGaD
Procainamide—Urticaria—Capecitabine—esophageal cancer	0.000386	0.00505	CcSEcCtD
Procainamide—Abdominal pain—Capecitabine—esophageal cancer	0.000384	0.00503	CcSEcCtD
Procainamide—Body temperature increased—Capecitabine—esophageal cancer	0.000384	0.00503	CcSEcCtD
Procainamide—Convulsion—Methotrexate—esophageal cancer	0.000384	0.00503	CcSEcCtD
Procainamide—Arthralgia—Methotrexate—esophageal cancer	0.000377	0.00494	CcSEcCtD
Procainamide—Myalgia—Methotrexate—esophageal cancer	0.000377	0.00494	CcSEcCtD
Procainamide—Discomfort—Methotrexate—esophageal cancer	0.000373	0.00488	CcSEcCtD
Procainamide—Confusional state—Methotrexate—esophageal cancer	0.000365	0.00477	CcSEcCtD
Procainamide—Hypersensitivity—Capecitabine—esophageal cancer	0.000358	0.00469	CcSEcCtD
Procainamide—Thrombocytopenia—Methotrexate—esophageal cancer	0.000354	0.00464	CcSEcCtD
Procainamide—Asthenia—Capecitabine—esophageal cancer	0.000349	0.00456	CcSEcCtD
Procainamide—Anorexia—Methotrexate—esophageal cancer	0.000345	0.00451	CcSEcCtD
Procainamide—Pruritus—Capecitabine—esophageal cancer	0.000344	0.0045	CcSEcCtD
Procainamide—Hypotension—Methotrexate—esophageal cancer	0.000338	0.00442	CcSEcCtD
Procainamide—Diarrhoea—Capecitabine—esophageal cancer	0.000333	0.00435	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00033	0.00431	CcSEcCtD
Procainamide—Dizziness—Capecitabine—esophageal cancer	0.000321	0.00421	CcSEcCtD
Procainamide—Decreased appetite—Methotrexate—esophageal cancer	0.000315	0.00412	CcSEcCtD
Procainamide—Vomiting—Capecitabine—esophageal cancer	0.000309	0.00404	CcSEcCtD
Procainamide—Feeling abnormal—Methotrexate—esophageal cancer	0.000298	0.0039	CcSEcCtD
Procainamide—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000296	0.00387	CcSEcCtD
Procainamide—Nausea—Capecitabine—esophageal cancer	0.000289	0.00378	CcSEcCtD
Procainamide—Urticaria—Methotrexate—esophageal cancer	0.000287	0.00376	CcSEcCtD
Procainamide—Body temperature increased—Methotrexate—esophageal cancer	0.000286	0.00374	CcSEcCtD
Procainamide—Abdominal pain—Methotrexate—esophageal cancer	0.000286	0.00374	CcSEcCtD
Procainamide—Hypersensitivity—Methotrexate—esophageal cancer	0.000267	0.00349	CcSEcCtD
Procainamide—Asthenia—Methotrexate—esophageal cancer	0.00026	0.0034	CcSEcCtD
Procainamide—Pruritus—Methotrexate—esophageal cancer	0.000256	0.00335	CcSEcCtD
Procainamide—Diarrhoea—Methotrexate—esophageal cancer	0.000248	0.00324	CcSEcCtD
Procainamide—Dizziness—Methotrexate—esophageal cancer	0.000239	0.00313	CcSEcCtD
Procainamide—Vomiting—Methotrexate—esophageal cancer	0.00023	0.00301	CcSEcCtD
Procainamide—Nausea—Methotrexate—esophageal cancer	0.000215	0.00281	CcSEcCtD
Procainamide—SLC22A3—Metabolism—GNG7—esophageal cancer	0.000132	0.000397	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—EP300—esophageal cancer	0.00013	0.000392	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—EP300—esophageal cancer	0.00013	0.000392	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	0.00013	0.00039	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYP26A1—esophageal cancer	0.000128	0.000387	CbGpPWpGaD
Procainamide—BCHE—Phospholipid metabolism—PIK3CA—esophageal cancer	0.000127	0.000383	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—CREBBP—esophageal cancer	0.000127	0.000382	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	0.000127	0.000382	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AKAP13—esophageal cancer	0.000126	0.000381	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CA2—esophageal cancer	0.000126	0.000379	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ADH7—esophageal cancer	0.000126	0.000378	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PLCE1—esophageal cancer	0.000126	0.000378	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—EGFR—esophageal cancer	0.000125	0.000377	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ALOX15—esophageal cancer	0.000125	0.000377	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ALDH2—esophageal cancer	0.000124	0.000372	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ADH1B—esophageal cancer	0.000123	0.000371	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—EGFR—esophageal cancer	0.00012	0.000361	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GSTO1—esophageal cancer	0.000119	0.00036	CbGpPWpGaD
Procainamide—ACHE—Metabolism—TPI1—esophageal cancer	0.000119	0.00036	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000119	0.000358	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—KMT2D—esophageal cancer	0.000118	0.000356	CbGpPWpGaD
Procainamide—BCHE—Metabolism—TYMP—esophageal cancer	0.000118	0.000355	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GSTT1—esophageal cancer	0.000118	0.000354	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PLCE1—esophageal cancer	0.000117	0.000352	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ADH7—esophageal cancer	0.000117	0.000352	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CYP2A6—esophageal cancer	0.000116	0.00035	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PDE4D—esophageal cancer	0.000116	0.000348	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—EGFR—esophageal cancer	0.000115	0.000347	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—EGFR—esophageal cancer	0.000115	0.000347	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AKAP13—esophageal cancer	0.000115	0.000346	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP26A1—esophageal cancer	0.000115	0.000345	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ALDOB—esophageal cancer	0.000114	0.000345	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—ERBB2—esophageal cancer	0.000113	0.000339	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ALOX15—esophageal cancer	0.000112	0.000336	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—EGFR—esophageal cancer	0.000111	0.000334	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—EGFR—esophageal cancer	0.000111	0.000334	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ENO1—esophageal cancer	0.00011	0.000332	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PTGS1—esophageal cancer	0.00011	0.000332	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GAPDH—esophageal cancer	0.00011	0.000332	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.00011	0.000332	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ADH1B—esophageal cancer	0.00011	0.000332	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—GNG7—esophageal cancer	0.00011	0.000331	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.00011	0.000331	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.00011	0.000331	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—EGFR—esophageal cancer	0.000109	0.000329	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CRABP1—esophageal cancer	0.000109	0.000329	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PSME1—esophageal cancer	0.000109	0.000327	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PSME2—esophageal cancer	0.000109	0.000327	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000108	0.000324	CbGpPWpGaD
Procainamide—BCHE—Metabolism—TPI1—esophageal cancer	0.000107	0.000321	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GSTO1—esophageal cancer	0.000107	0.000321	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.000106	0.00032	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADCYAP1—esophageal cancer	0.000105	0.000317	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—TYMP—esophageal cancer	0.000105	0.000317	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PDE4D—esophageal cancer	0.000105	0.000316	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—esophageal cancer	0.000105	0.000316	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GNG7—esophageal cancer	0.000104	0.000313	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000103	0.000311	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ADH1B—esophageal cancer	0.000103	0.000309	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP26A1—esophageal cancer	0.000102	0.000308	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ALDOB—esophageal cancer	0.000102	0.000308	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.0001	0.000302	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—GNG7—esophageal cancer	9.99e-05	0.000301	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ALOX15—esophageal cancer	9.97e-05	0.0003	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GAPDH—esophageal cancer	9.83e-05	0.000296	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—TYMP—esophageal cancer	9.81e-05	0.000295	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CRABP1—esophageal cancer	9.74e-05	0.000293	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ALDH2—esophageal cancer	9.73e-05	0.000293	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CXCL2—esophageal cancer	9.69e-05	0.000292	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	9.63e-05	0.00029	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—WWOX—esophageal cancer	9.63e-05	0.00029	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP26A1—esophageal cancer	9.54e-05	0.000287	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—TPI1—esophageal cancer	9.51e-05	0.000287	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GSTO1—esophageal cancer	9.51e-05	0.000287	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CYP1B1—esophageal cancer	9.37e-05	0.000282	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ALOX15—esophageal cancer	9.3e-05	0.00028	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GNG7—esophageal cancer	9.27e-05	0.000279	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GSTT1—esophageal cancer	9.26e-05	0.000279	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—EP300—esophageal cancer	9.16e-05	0.000276	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FKBP1A—esophageal cancer	9.16e-05	0.000276	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYP2A6—esophageal cancer	9.15e-05	0.000276	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ALDOB—esophageal cancer	9.12e-05	0.000275	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	9.12e-05	0.000275	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—esophageal cancer	9.11e-05	0.000274	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—ANXA1—esophageal cancer	9.01e-05	0.000271	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—WIF1—esophageal cancer	8.95e-05	0.00027	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SLC52A3—esophageal cancer	8.94e-05	0.000269	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—BLVRB—esophageal cancer	8.94e-05	0.000269	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—TPI1—esophageal cancer	8.87e-05	0.000267	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GSTO1—esophageal cancer	8.87e-05	0.000267	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CYP19A1—esophageal cancer	8.81e-05	0.000265	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CXCL2—esophageal cancer	8.8e-05	0.000265	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GAPDH—esophageal cancer	8.78e-05	0.000264	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—SST—esophageal cancer	8.76e-05	0.000264	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CRABP1—esophageal cancer	8.7e-05	0.000262	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ALDH2—esophageal cancer	8.68e-05	0.000262	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ENO1—esophageal cancer	8.68e-05	0.000261	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PTGS1—esophageal cancer	8.68e-05	0.000261	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PSME2—esophageal cancer	8.55e-05	0.000257	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PSME1—esophageal cancer	8.55e-05	0.000257	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—GHRL—esophageal cancer	8.54e-05	0.000257	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ALDOB—esophageal cancer	8.5e-05	0.000256	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GNG7—esophageal cancer	8.28e-05	0.000249	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GSTT1—esophageal cancer	8.26e-05	0.000249	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CSNK1A1—esophageal cancer	8.26e-05	0.000249	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GAPDH—esophageal cancer	8.18e-05	0.000246	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—ANXA1—esophageal cancer	8.18e-05	0.000246	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP2A6—esophageal cancer	8.16e-05	0.000246	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.13e-05	0.000245	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CRABP1—esophageal cancer	8.11e-05	0.000244	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—HMOX1—esophageal cancer	8.04e-05	0.000242	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—SST—esophageal cancer	7.96e-05	0.00024	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—EGFR—esophageal cancer	7.81e-05	0.000235	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—GHRL—esophageal cancer	7.76e-05	0.000234	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ALDH2—esophageal cancer	7.76e-05	0.000234	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ENO1—esophageal cancer	7.74e-05	0.000233	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PTGS1—esophageal cancer	7.74e-05	0.000233	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PFN1—esophageal cancer	7.73e-05	0.000233	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ABCB1—esophageal cancer	7.72e-05	0.000232	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GNG7—esophageal cancer	7.71e-05	0.000232	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PSME2—esophageal cancer	7.63e-05	0.00023	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PSME1—esophageal cancer	7.63e-05	0.00023	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CA1—esophageal cancer	7.6e-05	0.000229	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SLC10A2—esophageal cancer	7.6e-05	0.000229	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—MYC—esophageal cancer	7.53e-05	0.000227	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.47e-05	0.000225	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYP1B1—esophageal cancer	7.38e-05	0.000222	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GSTT1—esophageal cancer	7.38e-05	0.000222	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP2A6—esophageal cancer	7.29e-05	0.00022	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ALDH2—esophageal cancer	7.23e-05	0.000218	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CA2—esophageal cancer	6.95e-05	0.000209	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ELMO1—esophageal cancer	6.94e-05	0.000209	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYP19A1—esophageal cancer	6.94e-05	0.000209	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PTGS1—esophageal cancer	6.91e-05	0.000208	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ENO1—esophageal cancer	6.91e-05	0.000208	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	6.91e-05	0.000208	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GSTT1—esophageal cancer	6.88e-05	0.000207	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PSME2—esophageal cancer	6.81e-05	0.000205	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PSME1—esophageal cancer	6.81e-05	0.000205	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP2A6—esophageal cancer	6.8e-05	0.000205	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKAP13—esophageal cancer	6.78e-05	0.000204	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.66e-05	0.000201	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP1B1—esophageal cancer	6.58e-05	0.000198	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PLCE1—esophageal cancer	6.46e-05	0.000195	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ADH7—esophageal cancer	6.46e-05	0.000195	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ENO1—esophageal cancer	6.44e-05	0.000194	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PTGS1—esophageal cancer	6.44e-05	0.000194	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	6.44e-05	0.000194	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PSME2—esophageal cancer	6.35e-05	0.000191	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PSME1—esophageal cancer	6.35e-05	0.000191	CbGpPWpGaD
Procainamide—ACHE—Metabolism—HMOX1—esophageal cancer	6.33e-05	0.000191	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HIST1H2BM—esophageal cancer	6.26e-05	0.000189	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.21e-05	0.000187	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PDE4D—esophageal cancer	6.2e-05	0.000187	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP19A1—esophageal cancer	6.19e-05	0.000186	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ABCB1—esophageal cancer	6.08e-05	0.000183	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GNG7—esophageal cancer	5.9e-05	0.000178	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP1B1—esophageal cancer	5.88e-05	0.000177	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ADH1B—esophageal cancer	5.67e-05	0.000171	CbGpPWpGaD
Procainamide—BCHE—Metabolism—HMOX1—esophageal cancer	5.65e-05	0.00017	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.54e-05	0.000167	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—XIAP—esophageal cancer	5.53e-05	0.000167	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP19A1—esophageal cancer	5.53e-05	0.000166	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP1B1—esophageal cancer	5.48e-05	0.000165	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ABCB1—esophageal cancer	5.42e-05	0.000163	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—TYMP—esophageal cancer	5.42e-05	0.000163	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP26A1—esophageal cancer	5.27e-05	0.000159	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CTNNA1—esophageal cancer	5.23e-05	0.000157	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCL2—esophageal cancer	5.2e-05	0.000157	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CREBBP—esophageal cancer	5.16e-05	0.000155	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP19A1—esophageal cancer	5.15e-05	0.000155	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALOX15—esophageal cancer	5.13e-05	0.000155	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—HMOX1—esophageal cancer	5.04e-05	0.000152	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—TPI1—esophageal cancer	4.9e-05	0.000148	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GSTO1—esophageal cancer	4.9e-05	0.000148	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PSME1—esophageal cancer	4.86e-05	0.000146	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PSME2—esophageal cancer	4.86e-05	0.000146	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ABCB1—esophageal cancer	4.84e-05	0.000146	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ANXA1—esophageal cancer	4.83e-05	0.000146	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SST—esophageal cancer	4.7e-05	0.000142	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—HMOX1—esophageal cancer	4.7e-05	0.000142	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALDOB—esophageal cancer	4.7e-05	0.000141	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—NOS3—esophageal cancer	4.62e-05	0.000139	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.59e-05	0.000138	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NOTCH3—esophageal cancer	4.58e-05	0.000138	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GHRL—esophageal cancer	4.58e-05	0.000138	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GAPDH—esophageal cancer	4.52e-05	0.000136	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ABCB1—esophageal cancer	4.51e-05	0.000136	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FBXW7—esophageal cancer	4.51e-05	0.000136	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CRABP1—esophageal cancer	4.48e-05	0.000135	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GNG7—esophageal cancer	4.26e-05	0.000128	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PTGS2—esophageal cancer	4.22e-05	0.000127	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NOTCH2—esophageal cancer	4.11e-05	0.000124	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.1e-05	0.000123	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CREBBP—esophageal cancer	4.06e-05	0.000122	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALDH2—esophageal cancer	3.99e-05	0.00012	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GSTT1—esophageal cancer	3.8e-05	0.000114	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP2A6—esophageal cancer	3.75e-05	0.000113	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TGFBR2—esophageal cancer	3.65e-05	0.00011	CbGpPWpGaD
Procainamide—ACHE—Metabolism—NOS3—esophageal cancer	3.64e-05	0.000109	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CREBBP—esophageal cancer	3.62e-05	0.000109	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ENO1—esophageal cancer	3.56e-05	0.000107	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PTGS1—esophageal cancer	3.56e-05	0.000107	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—EP300—esophageal cancer	3.51e-05	0.000106	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PSME1—esophageal cancer	3.51e-05	0.000106	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PSME2—esophageal cancer	3.51e-05	0.000106	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SMAD4—esophageal cancer	3.45e-05	0.000104	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PTGS2—esophageal cancer	3.32e-05	0.0001	CbGpPWpGaD
Procainamide—BCHE—Metabolism—NOS3—esophageal cancer	3.24e-05	9.77e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CREBBP—esophageal cancer	3.24e-05	9.74e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP1B1—esophageal cancer	3.03e-05	9.11e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CREBBP—esophageal cancer	3.02e-05	9.08e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PTGS2—esophageal cancer	2.97e-05	8.93e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—NOS3—esophageal cancer	2.9e-05	8.72e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP19A1—esophageal cancer	2.85e-05	8.57e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HIF1A—esophageal cancer	2.82e-05	8.5e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—EP300—esophageal cancer	2.77e-05	8.33e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—KDR—esophageal cancer	2.7e-05	8.13e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—NOS3—esophageal cancer	2.7e-05	8.13e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PTGS2—esophageal cancer	2.65e-05	7.98e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PIK3CA—esophageal cancer	2.6e-05	7.83e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HMOX1—esophageal cancer	2.6e-05	7.82e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NOTCH1—esophageal cancer	2.54e-05	7.66e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ABCB1—esophageal cancer	2.49e-05	7.5e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PTGS2—esophageal cancer	2.47e-05	7.44e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—EP300—esophageal cancer	2.47e-05	7.43e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CREBBP—esophageal cancer	2.31e-05	6.95e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—EGFR—esophageal cancer	2.27e-05	6.83e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—EP300—esophageal cancer	2.2e-05	6.64e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PIK3CA—esophageal cancer	2.17e-05	6.52e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NOS3—esophageal cancer	2.07e-05	6.22e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—EP300—esophageal cancer	2.05e-05	6.18e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PIK3CA—esophageal cancer	2.05e-05	6.16e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PIK3CA—esophageal cancer	1.97e-05	5.92e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ERBB2—esophageal cancer	1.93e-05	5.82e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PIK3CA—esophageal cancer	1.82e-05	5.5e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCND1—esophageal cancer	1.71e-05	5.14e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CREBBP—esophageal cancer	1.67e-05	5.02e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CDKN1A—esophageal cancer	1.65e-05	4.97e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PIK3CA—esophageal cancer	1.63e-05	4.91e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EP300—esophageal cancer	1.57e-05	4.73e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PIK3CA—esophageal cancer	1.52e-05	4.57e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NOS3—esophageal cancer	1.49e-05	4.49e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MYC—esophageal cancer	1.37e-05	4.12e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PTGS2—esophageal cancer	1.36e-05	4.11e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EGFR—esophageal cancer	1.34e-05	4.03e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PIK3CA—esophageal cancer	1.16e-05	3.5e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—EP300—esophageal cancer	1.13e-05	3.42e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TP53—esophageal cancer	1.12e-05	3.39e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIK3CA—esophageal cancer	8.39e-06	2.53e-05	CbGpPWpGaD
